Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2.

Teresa Corazzi,M. Leone,R. Roberti,P. del Soldato,P. Gresele

DOI: https://doi.org/10.1016/J.BBRC.2003.10.079

2003-11-28

Abstract:

What problem does this paper attempt to address?

Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

T. Hedges,L. Vuong,Alberto O. González-García,C. Mendoza-Santiesteban,Maria Luz Amaro-Quierza

DOI: https://doi.org/10.1001/archopht.126.6.812

2008-06-09

A M A Archives of Ophthalmology

Abstract:OBJECTIVE To demonstrate the development of subfoveal fluid associated with optic disc swelling from nonarteritic anterior ischemic optic neuropathy. METHODS Optical coherence tomographic studies obtained during a 3-year period (October 1, 2003, to December 30, 2006) from 76 patients who developed ischemic optic neuropathy from 2 institutions were evaluated. The presence or absence, and the distribution, of subretinal fluid was determined. RESULTS Seventy-six patients underwent macular optical coherence tomography within 4 weeks of developing sudden loss of vision in one eye, decreased visual acuity, a visual field defect, a relative afferent pupillary defect, and optic disc swelling with peripapillary hemorrhages. Eight patients had apparent subretinal fluid extending into the subfoveal space. Visual acuity improved in 5 of the 8 patients as the subfoveal fluid resolved. CONCLUSIONS Subretinal fluid develops in some patients with nonarteritic anterior ischemic optic neuropathy and may contribute to some of the visual loss associated with this condition. Furthermore, resolution of the subretinal fluid could account for some of the visual improvement that can follow anterior ischemic optic neuropathy.
Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria

Kyle Mangano,Tanja Florin,Xinhao Shao,Dorota Klepacki,Irina Chelysheva,Zoya Ignatova,Yu Gao,Alexander S Mankin,Nora Vázquez-Laslop

DOI: https://doi.org/10.7554/elife.62655

IF: 7.7

2020-10-08

eLife

Abstract:Biochemical studies suggested that the antimicrobial peptide apidaecin (Api) inhibits protein synthesis by binding in the nascent peptide exit tunnel and trapping the release factor associated with a terminating ribosome. The mode of Api action in bacterial cells had remained unknown. Here genome-wide analysis reveals that in bacteria, Api arrests translating ribosomes at stop codons and causes pronounced queuing of the trailing ribosomes. By sequestering the available release factors, Api promotes pervasive stop codon bypass, leading to the expression of proteins with C-terminal extensions. Api-mediated translation arrest leads to the futile activation of the ribosome rescue systems. Understanding the unique mechanism of Api action in living cells may facilitate the development of new medicines and research tools for genome exploration.

biology
Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88

Simon M Lauer,Maren Reepmeyer,Ole Berendes,Dorota Klepacki,Jakob Gasse,Sara Gabrielli,Helmut Grubmüller,Lars V Bock,Andor Krizsan,Rainer Nikolay,Christian M T Spahn,Ralf Hoffmann

DOI: https://doi.org/10.1038/s41467-024-48027-4

2024-05-10

Abstract:Proline-rich antimicrobial peptides (PrAMPs) inhibit bacterial protein biosynthesis by binding to the polypeptide exit tunnel (PET) near the peptidyl transferase center. Api137, an optimized derivative of honeybee PrAMP apidaecin, inhibits protein expression by trapping release factors (RFs), which interact with stop codons on ribosomes to terminate translation. This study uses cryo-EM, functional assays and molecular dynamic (MD) simulations to show that Api137 additionally occupies a second binding site near the exit of the PET and can repress translation independently of RF-trapping. Api88, a C-terminally amidated (-CONH2) analog of Api137 (-COOH), binds to the same sites, occupies a third binding pocket and interferes with the translation process presumably without RF-trapping. In conclusion, apidaecin-derived PrAMPs inhibit bacterial ribosomes by multimodal mechanisms caused by minor structural changes and thus represent a promising pool for drug development efforts.
An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome

Tanja Florin,Cristina Maracci,Michael Graf,Prajwal Karki,Dorota Klepacki,Otto Berninghausen,Roland Beckmann,Nora Vázquez-Laslop,Daniel N Wilson,Marina V Rodnina,Alexander S Mankin

DOI: https://doi.org/10.1038/nsmb.3439

2017-07-24

Abstract:Antimicrobial peptide Api137 inhibits translation by trapping release factors 1 or 2 associated with ribosomes and arresting termination.

cell biology,biochemistry & molecular biology,biophysics
Structural and mechanistic insights into translation termination

Portia Gloria Loh,Haiwei Song

DOI: https://doi.org/10.1016/j.sbi.2009.12.005

IF: 7.786

2010-01-01

Current Opinion in Structural Biology

Abstract:Translation termination is mediated by two classes of peptide release factors (RFs). Class I RF recognizes the stop codons and triggers the release of the polypeptide chain. Class II RF in prokaryotes promotes dissociation of class I RFs from the ribosome whereas in eukaryotes it acts cooperatively with class I RF to ensure efficient stop codon recognition and fast peptide release. Advances have been made in recent years at astonishing pace to determine the high-resolution crystal structures of both classes of RFs on and off the ribosome. Combined with biochemical analyses, these structures provide considerable insights into the mechanistic principles of stop codon recognition and peptide release.
RAPP-containing arrest peptides induce translational stalling by short circuiting the ribosomal peptidyltransferase activity

Martino Morici,Sara Gabrielli,Keigo Fujiwara,Helge Paternoga,Bertrand Beckert,Lars V. Bock,Shinobu Chiba,Daniel N. Wilson

DOI: https://doi.org/10.1038/s41467-024-46761-3

IF: 16.6

2024-03-19

Nature Communications

Abstract:Abstract Arrest peptides containing RAPP (ArgAlaProPro) motifs have been discovered in both Gram-positive and Gram-negative bacteria, where they are thought to regulate expression of important protein localization machinery components. Here we determine cryo-EM structures of ribosomes stalled on RAPP arrest motifs in both Bacillus subtilis and Escherichia coli . Together with molecular dynamics simulations, our structures reveal that the RAPP motifs allow full accommodation of the A-site tRNA, but prevent the subsequent peptide bond from forming. Our data support a model where the RAP in the P-site interacts and stabilizes a single hydrogen atom on the Pro-tRNA in the A-site, thereby preventing an optimal geometry for the nucleophilic attack required for peptide bond formation to occur. This mechanism to short circuit the ribosomal peptidyltransferase activity is likely to operate for the majority of other RAPP-like arrest peptides found across diverse bacterial phylogenies.

multidisciplinary sciences
Transcription Inhibition by the Depsipeptide Antibiotic Salinamide A

David Degen,Yu Feng,Yu Zhang,Katherine Y. Ebright,Yon W. Ebright,Matthew Gigliotti,Hanif Vahedian-Movahed,Sukhendu Mandal,Meliza Talaue,Nancy Connell,Eddy Arnold,William Fenical,Richard H. Ebright

DOI: https://doi.org/10.7554/elife.02451

IF: 7.7

2014-01-01

eLife

Abstract:We report that bacterial RNA polymerase (RNAP) is the functional cellular target of the depsipeptide antibiotic salinamide A (Sal), and we report that Sal inhibits RNAP through a novel binding site and mechanism. We show that Sal inhibits RNA synthesis in cells and that mutations that confer Sal-resistance map to RNAP genes. We show that Sal interacts with the RNAP active-center 'bridge-helix cap' comprising the 'bridge-helix N-terminal hinge', 'F-loop', and 'link region'. We show that Sal inhibits nucleotide addition in transcription initiation and elongation. We present a crystal structure that defines interactions between Sal and RNAP and effects of Sal on RNAP conformation. We propose that Sal functions by binding to the RNAP bridge-helix cap and preventing conformational changes of the bridge-helix N-terminal hinge necessary for nucleotide addition. The results provide a target for antibacterial drug discovery and a reagent to probe conformation and function of the bridge-helix N-terminal hinge.
Design of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho

Gairika Ghosh,Pankaj V. Sharma,Amit Kumar,Sriyans Jain,Ranjan Sen

DOI: https://doi.org/10.1016/j.jbc.2021.100653

IF: 5.485

2021-01-01

Journal of Biological Chemistry

Abstract:The transcription terminator Rho regulates many physiological processes in bacteria, such as antibiotic sensitivity, DNA repair, RNA remodeling, and so forth, and hence, is a potential antimicrobial target, which is unexplored. The bacteriophage P4 capsid protein, Psu, moonlights as a natural Rho antagonist. Here, we report the design of novel peptides based on the C-terminal region of Psu using phenotypic screening methods. The resultant 38-mer peptides, in addition to containing mutagenized Psu sequences, also contained plasmid sequences, fused to their C termini. Expression of these peptides inhibited the growth of Escherichia coli and specifically inhibited Rho-dependent termination in vivo. Peptides 16 and 33 exhibited the best Rho-inhibitory properties in vivo. Direct high-affinity binding of these two peptides to Rho also inhibited the latter's RNA-dependent ATPase and transcription termination functions in vitro. These two peptides remained functional even if eight to ten amino acids were deleted from their C termini. In silico modeling and genetic and biochemical evidence revealed that these two peptides bind to the primary RNA-binding site of the Rho hexamer near its subunit interfaces. In addition, the gene expression profiles of these peptides and Psu overlapped significantly. These peptides also inhibited the growth of Mycobacteria and inhibited the activities of Rho proteins from Mycobacterium tuberculosis, Xanthomonas, Vibrio cholerae, and Salmonella enterica. Our results showed that these novel anti-Rho peptides mimic the Rho-inhibition function of the ∼42-kDa dimeric bacteriophage P4 capsid protein, Psu. We conclude that these peptides and their C-terminal deletion derivatives could provide a basis on which to design novel antimicrobial peptides.

biochemistry & molecular biology
Selective inhibition of human translation termination by a drug-like compound

Wenfei Li,Stacey Tsai-Lan Chang,Fred. R. Ward,Jamie H. D. Cate

DOI: https://doi.org/10.1038/s41467-020-18765-2

IF: 16.6

2020-10-02

Nature Communications

Abstract:Abstract Methods to directly inhibit gene expression using small molecules hold promise for the development of new therapeutics targeting proteins that have evaded previous attempts at drug discovery. Among these, small molecules including the drug-like compound PF-06446846 (PF846) selectively inhibit the synthesis of specific proteins, by stalling translation elongation. These molecules also inhibit translation termination by an unknown mechanism. Using cryo-electron microscopy (cryo-EM) and biochemical approaches, we show that PF846 inhibits translation termination by arresting the nascent chain (NC) in the ribosome exit tunnel. The arrested NC adopts a compact α-helical conformation that induces 28 S rRNA nucleotide rearrangements that suppress the peptidyl transferase center (PTC) catalytic activity stimulated by eukaryotic release factor 1 (eRF1). These data support a mechanism of action for a small molecule targeting translation that suppresses peptidyl-tRNA hydrolysis promoted by eRF1, revealing principles of eukaryotic translation termination and laying the foundation for new therapeutic strategies.

multidisciplinary sciences
Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity

Alexandra Brakel,Andor Krizsan,Renke Itzenga,Carl N. Kraus,Laszlo Otvos,Ralf Hoffmann

DOI: https://doi.org/10.3390/ijms23063150

IF: 5.6

2022-03-15

International Journal of Molecular Sciences

Abstract:Proline-rich antimicrobial peptides (PrAMPs) are promising candidates to treat bacterial infections. The designer peptide ARV-1502 exhibits strong antimicrobial effects against Enterobacteriaceae both in vitro and in vivo. Since the inhibitory effects of ARV-1502 reported for the 70 kDa heat-shock protein DnaK do not fully explain the antimicrobial activity of its 176 substituted analogs, we further studied their effect on the bacterial 70S ribosome of Escherichia coli, a known target of PrAMPs. ARV-1502 analogues, substituted in positions 3, 4, and 8 to 12 (underlined) of the binding motif D3KPRPYLPRP12 with aspartic acid, lysine, serine, phenylalanine or leucine, were tested in a competitive fluorescence polarization (FP) binding screening assay using 5(6)-carboxyfluorescein-labeled (Cf-) ARV-1502 and the 70S ribosome isolated from E. coli BW25113. While their effect on ribosomal protein expression was studied for green fluorescent protein (GFP) in a cell-free expression system (in vitro translation), the importance of known PrAMP transporters SbmA and MdtM was investigated using E. coli BW25113 and the corresponding knockout mutants. The dissociation constant (Kd) of 201 ± 16 nmol/L obtained for Cf-ARV-1502 suggests strong binding to the E. coli 70S ribosome. An inhibitory binding assay indicated that the binding site overlaps with those of other PrAMPs including Onc112 and pyrrhocoricin as well as the non-peptidic antibiotics erythromycin and chloramphenicol. All these drugs and drug candidates bind to the exit-tunnel of the 70S ribosome. Substitutions of the C-terminal fragment of the binding motif YLPRP reduced binding. At the same time, inhibition of GFP expression increased with net peptide charge. Interestingly, the MIC values of wild-type and ΔsbmA and ΔmdtM knockout mutants indicated that substitutions in the ribosomal binding motif altered also the bacterial uptake, which was generally improved by incorporation of hydrophobic residues. In conclusion, most substituted ARV-1502 analogs bound weaker to the 70S ribosome than ARV-1502 underlining the importance of the YLPRP binding motif. The weaker ribosomal binding correlated well with decreased antimicrobial activity in vitro. Substituted ARV-1502 analogs with a higher level of hydrophobicity or positive net charge improved the ribosome binding, inhibition of translation, and bacterial uptake.

biochemistry & molecular biology,chemistry, multidisciplinary
Activity, structure, and diversity of Type II proline-rich antimicrobial peptides from insects

Weiping Huang,Chetana Baliga,Elena V Aleksandrova,Gemma Atkinson,Yury S Polikanov,Nora Vázquez-Laslop,Alexander S Mankin

DOI: https://doi.org/10.1038/s44319-024-00277-5

Abstract:Apidaecin 1b (Api), the first characterized Type II Proline-rich antimicrobial peptide (PrAMP), is encoded in the honey bee genome. It inhibits bacterial growth by binding in the nascent peptide exit tunnel of the ribosome after the release of the completed protein and trapping the release factors. By genome mining, we have identified 71 PrAMPs encoded in insect genomes as pre-pro-polyproteins. Having chemically synthesized and tested the activity of 26 peptides, we demonstrate that despite significant sequence variation in the N-terminal sequence, the majority of the PrAMPs that retain the conserved C-terminal sequence of Api are able to trap the ribosome at the stop codons and induce stop codon readthrough-all hallmarks of Type II PrAMP mode of action. Some of the characterized PrAMPs exhibit superior antibacterial activity in comparison with Api. The newly solved crystallographic structures of the ribosome complexed with Api and with the more active peptide Fva1 from the stingless bee demonstrate the universal placement of the PrAMPs' C-terminal pharmacophore in the post-release ribosome despite variations in their N-terminal sequence.
Conserved Function of Drg GTPases in Promoting Protein Synthesis in Stalled Ribosomes

Christopher W. Hawk,Hong Jin

DOI: https://doi.org/10.1101/2024.04.20.590341

2024-04-21

Abstract:Maintaining proper protein homeostasis is essential for cell physiology. The ribosome and GTPases, which are two of the most ancient and critical cellular molecules, are central players in protein synthesis and its regulation. Here we report the discovery of a new general translation factor that targets stalled ribosomes and promotes protein synthesis in an evolutionarily conserved manner. We show that the essential bacterial Obg GTPases are distant homologs of eukaryotic and archaeal Drg proteins and serve critical roles in promoting efficient protein translation in stalled ribosomes. Through characterization, including cross-species complementation of cells where ribosomes are induced to stall by addition of either the antibiotic anisomycin or exogenous mRNA harboring a long poly(A) sequence, we demonstrate that a conserved function of Drg proteins is to alleviate ribosomal stalling during translation. Our data show that bacterial Obg rescues stalled ribosomes in both Saccharomyces cerevisiae and human cells lacking endogenous Drgs, as does supplementation of the respective endogenous Drg proteins from yeast and human cells. Furthermore, the presence of ObgE and GTP stimulates peptidyl transfer, the key catalytic function of the ribosome, suggesting a possible molecular mechanism of this GTPase to enhance translation in stalled ribosomes. This discovery shows that the Drg protein is a new general translation factor that directly affords cells from the three domains of life a new form of translation regulation.

Molecular Biology
Drosophila immunity: the Drosocin gene encodes two host defence peptides with pathogen-specific roles

M. A. HansonS. KondoB. Lemaitre1Global Health Institute,School of Life Science,École Polytechnique Fédérale de Lausanne (EPFL),Lausanne,Switzerland2Invertebrate Genetics Laboratory,Genetic Strains Research Center,National Institute of Genetics,Mishima,Japan

DOI: https://doi.org/10.1098/rspb.2022.0773

2022-06-23

Proceedings of the Royal Society B: Biological Sciences

Abstract:Antimicrobial peptides (AMPs) are key to defence against infection in plants and animals. Use of AMP mutations in Drosophila has now revealed that AMPs can additively or synergistically contribute to defence in vivo . However, these studies also revealed high specificity, wherein just one AMP contributes an outsized role in combatting a specific pathogen. Here, we show the Drosocin locus ( CG10816 ) is more complex than previously described. In addition to its namesake peptide 'Drosocin', it encodes a second mature peptide from a precursor via furin cleavage. This peptide corresponds to the previously uncharacterized 'Immune-induced Molecule 7'. A polymorphism (Thr52Ala) in the Drosocin precursor protein previously masked the identification of this peptide, which we name 'Buletin'. Using mutations differently affecting Drosocin and Buletin, we show that only Drosocin contributes to Drosocin gene-mediated defence against Enterobacter cloacae . Strikingly, we observed that Buletin, but not Drosocin, contributes to the Drosocin gene-mediated defence against Providencia burhodogranariea , including an importance of the Thr52Ala polymorphism for survival. Our study reveals that the Drosocin gene encodes two prominent host defence peptides with different specificity against distinct pathogens. This finding emphasizes the complexity of the Drosophila humoral response and demonstrates how natural polymorphisms can affect host susceptibility.
Distant Ribose 2'-O-Methylation of 23S rRNA Helix 69 Pre-Orders the Capreomycin Drug Binding Pocket at the Ribosome Subunit Interface

Suparno Nandi,Debayan Dey,Pooja Srinivas,Christine M Dunham,Graeme L Conn

DOI: https://doi.org/10.1101/2024.11.05.619916

2024-11-05

Abstract:Loss of ribosomal RNA (rRNA) modifications incorporated by the intrinsic methyltransferase TlyA results in reduced sensitivity to tuberactinomycin antibiotics such as capreomycin. However, the mechanism by which rRNA methylation alters drug binding, particularly at the distant but functionally more important site in 23S rRNA Helix 69 (H69), is currently unknown. We determined high-resolution cryo-electron microscopy structures of the Mycolicibacterium smegmatis 70S ribosome with or without the two ribose 2'-O-methyl modifications incorporated by TlyA. In the unmodified ribosome, the tip of H69 adopts a more compact conformation, positioning two key nucleotides (A2137 and C2138) such that interactions with capreomycin would be lost and the binding pocket partially occluded. In contrast, methylation of 23S rRNA nucleotide C2144 results in conformational changes that propagate from the site of modification to the H69 tip, resulting in its movement away from h44, a more favorable positioning of C2138 and adoption of a more open conformation to enable capreomycin binding. Methylation of h44 also results in structural rearrangements at the H69-h44 interface that further support antibiotic binding. These structures thus reveal the effect and regulation of distant rRNA methylation on ribosome-targeting antibiotic binding.

Microbiology
Doderlin: Isolation and Characterization of a Broad-Spectrum Antimicrobial Peptide from Lactobacillus acidophilus

Bruna S. da Silva,Andrea Díaz-Roa,Erica S. Yamane,Mirian A. F. Hayashi,Pedro Ismael da Silva Junior

DOI: https://doi.org/10.1101/2022.01.19.476933

2022-01-20

Abstract:ABSTRACT Lactobacillus acidophilus are Gram-positive bacteria distributed in diverse environments, and as being a component of the normal microbiota of gastrointestinal and urogenital tract, being relevant to humans. Classified as lactic acid bacteria, due to the pro-duction of lactic acid, Lactobacillus can also produce antimicrobial peptides (AMPs), which is a compound synthesized by all forms of life aiming for protecting themselves from threats and to increase their competitivity to survive in a specific environment. AMPs are molecules capable of inhibiting the growth of microorganisms and, due to the indiscriminate use of conventional antibiotics and the emergence of multi-resistant bacteria, they have become an alternative, not only for treating multi-resistant infections, but also for probiotic product confection and food conservation. Considering the rampant rise of resistance, the present study aimed to isolate and characterize antimicrobial peptides from Lactobacillus acidophilus extracts. Samples were obtained from Lactobacillus acid extract supernatant which was pre-fractionated on disposable cartridges, followed by a high-performance liquid chromatography (HPLC). The collected fractions were evaluated in a liquid growth inhibition assay where eight fractions antimicrobial activity were obtained. One of them was selected for further characterization by mass spectrometry (MS), due to its antimicrobial activity against Candida albicans and conclusive results in mass spectrometry analysis. This molecule was identified as a peptide having a molecular mass of 1788.01 Da, peptide sequence NEPTHLLKAFSKAGFQ, and named Doderlin. Interestingly, antimicrobial molecules isolated from L. acidophilus have already been described previously, but few reports in the literature describe an AMP effective against C. albicans as reported here. The results obtained suggest that this newly discovered molecule have a biological property with potential to be applied in pharmaceutical and food companies in the fight against contamination and/or for treating infections caused by microorganisms. IMPORTANCE Doderlin, this newly discovered molecule have a biological property with potential to be applied in pharmaceutical and food companies in the fight against contamination and/or for treating infections caused by microorganisms.
Antibacterial Peptide Nucleic Acid-Antimicrobial Peptide (PNA-AMP) Conjugates: Antisense Targeting of Fatty Acid Biosynthesis.

C. J. Larsen,H. Franzyk,A. Hansen,P. Nielsen,Gitte Bonke,Niloofar Yavari

DOI: https://doi.org/10.1021/acs.bioconjchem.6b00013

IF: 4.7

2016-03-10

Bioconjugate Chemistry

Abstract:Antisense peptide nucleic acid (PNA) oligomers constitute a novel class of potential antibiotics that inhibit bacterial growth via specific knockdown of essential gene expression. However, discovery of efficient, nontoxic delivery vehicles for such PNA oligomers has remained a challenge. In the present study we show that antimicrobial peptides (AMPs) with an intracellular mode of action can be efficient vehicles for bacterial delivery of an antibacterial PNA targeting the essential acpP gene. The results demonstrate that buforin 2-A (BF2-A), drosocin, oncocin 10, Pep-1-K, KLW-9,13-a, (P59→W59)-Tat48-60, BF-2A-RXR, and drosocin-RXR are capable of transporting PNA effectively into E. coli (MICs of 1-4 μM). Importantly, presence of the inner-membrane peptide transporter SbmA was not required for antibacterial activity of PNA-AMP conjugates containing Pep-1-K, KLW-9,13-a, or drosocin-RXR (MICs of 2-4 μM).

Chemistry,Medicine,Biology
Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

Ilya A. Osterman,Maximiliane Wieland,Tinashe P. Maviza,Kseniya A. Lashkevich,Dmitrii A. Lukianov,Ekaterina S. Komarova,Yuliya V. Zakalyukina,Robert Buschauer,Dmitrii I. Shiriaev,Semen A. Leyn,Jaime E. Zlamal,Mikhail V. Biryukov,Dmitry A. Skvortsov,Vadim N. Tashlitsky,Vladimir I. Polshakov,Jingdong Cheng,Yury S. Polikanov,Alexey A. Bogdanov,Andrei L. Osterman,Sergey E. Dmitriev,Roland Beckmann,Olga A. Dontsova,Daniel N. Wilson,Petr V. Sergiev

DOI: https://doi.org/10.1038/s41589-020-0578-x

IF: 14.8

2020-01-01

Nature Chemical Biology

Abstract:The increase in multi-drug resistant pathogenic bacteria is making our current arsenal of clinically used antibiotics obsolete, highlighting the urgent need for new lead compounds with distinct target binding sites to avoid cross-resistance. Here we report that the aromatic polyketide antibiotic tetracenomycin (TcmX) is a potent inhibitor of protein synthesis, and does not induce DNA damage as previously thought. Despite the structural similarity to the well-known translation inhibitor tetracycline, we show that TcmX does not interact with the small ribosomal subunit, but rather binds to the large subunit, within the polypeptide exit tunnel. This previously unappreciated binding site is located adjacent to the macrolide-binding site, where TcmX stacks on the noncanonical basepair formed by U1782 and U2586 of the 23S ribosomal RNA. Although the binding site is distinct from the macrolide antibiotics, our results indicate that like macrolides, TcmX allows translation of short oligopeptides before further translation is blocked.
Rumicidins are a family of mammalian host-defense peptides plugging the 70S ribosome exit tunnel

Pavel V Panteleev,Eugene B Pichkur,Roman N Kruglikov,Alena Paleskava,Olga V Shulenina,Ilia A Bolosov,Ivan V Bogdanov,Victoria N Safronova,Sergey V Balandin,Valeriya I Marina,Tatiana I Kombarova,Olga V Korobova,Olga V Shamova,Alexander G Myasnikov,Alexander I Borzilov,Ilya A Osterman,Petr V Sergiev,Alexey A Bogdanov,Olga A Dontsova,Andrey L Konevega,Tatiana V Ovchinnikova

DOI: https://doi.org/10.1038/s41467-024-53309-y

2024-10-16

Abstract:The antimicrobial resistance crisis along with challenges of antimicrobial discovery revealed the vital necessity to develop new antibiotics. Many of the animal proline-rich antimicrobial peptides (PrAMPs) inhibit the process of bacterial translation. Genome projects allowed to identify immune-related genes encoding animal host defense peptides. Here, using genome mining approach, we discovered a family of proline-rich cathelicidins, named rumicidins. The genes encoding these peptides are widespread among ruminant mammals. Biochemical studies indicated that rumicidins effectively inhibited the elongation stage of bacterial translation. The cryo-EM structure of the Escherichia coli 70S ribosome in complex with one of the representatives of the family revealed that the binding site of rumicidins span the ribosomal A-site cleft and the nascent peptide exit tunnel interacting with its constriction point by the conservative Trp23-Phe24 dyad. Bacterial resistance to rumicidins is mediated by knockout of the SbmA transporter or modification of the MacAB-TolC efflux pump. A wide spectrum of antibacterial activity, a high efficacy in the animal infection model, and lack of adverse effects towards human cells in vitro make rumicidins promising molecular scaffolds for development of ribosome-targeting antibiotics.
A newly-identified mini-hairpin shaped nascent peptide blocks translation termination by a novel mechanism.

Yushin Ando,Akinao Kobo,Tatsuya Niwa,Ayako Yamakawa,Suzuna Konoma,Yuki Kobayashi,Osamu Nureki,Hideki Taguchi,Yuzuru Itoh,Yuhei Chadani

DOI: https://doi.org/10.1101/2024.05.31.596752

2024-06-01

Abstract:Protein synthesis by ribosomes not only produces functional proteins but also serves diverse functions depending on the coding amino acid sequences. Certain nascent peptides interact with the ribosome exit tunnel to arrest translation and modulate the expression of downstream genes or themselves. However, a comprehensive understanding of the mechanisms of such ribosome stalling and its regulation remains elusive. In this study, we systematically screened for unidentified ribosome arrest peptides through phenotypic evaluation, proteomics, and MS analyses, leading to the discovery of novel arrest peptides PepNL and NanCL in E. coli. Our cryo-EM study on PepNL revealed a unique arrest mechanism, in which the N-terminus of PepNL folds back towards the tunnel entrance to prevent the catalytic GGQ motif of release factor from accessing the peptidyl transferase center, causing translation arrest at the UGA stop codon. Furthermore, unlike other sensory arrest peptides that require an arrest inducer, PepNL uses tryptophan as an arrest releaser, where Trp-tRNA reads through the stop codon. Our findings illuminate the mechanism and regulatory framework of nascent peptide-induced translation arrest, paving the way for exploring regulatory nascent peptides.

Molecular Biology
A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1

Elvira Alanis,Faith Aguilar,Niaz Banaei,Frank B. Dean,Alexa Villarreal,Miguel Alanis,Karen Lozano,James M. Bullard,Yonghong Zhang

DOI: https://doi.org/10.1128/spectrum.02773-23

IF: 3.7

2024-02-09

Microbiology Spectrum

Abstract:Bacterial infections continue to represent a major worldwide health hazard due to the emergence of drug-resistant strains. Clostridioides difficile is a common nosocomial pathogen and the causative agent in many infections resulting in an increase in morbidity and mortality. Bacterial protein synthesis is an essential metabolic process and an important target for antibiotic development; however, the precise structural mechanism underlying the process in C. difficile remains unknown. This study reports the solution structure of C. difficile translation initiation factor 1 (IF1) and its interaction with the 30S ribosomal subunit. A short α-helix in IF1 structure was identified as critically important for ribosomal binding and function in regulating the translation initiation, which allowed a rational design of a new peptide. The peptide demonstrated a high ability to inhibit bacterial growth with broad-spectrum antibacterial activity. This study provides a new clue for the rational design of new antimicrobials against bacterial infections.

microbiology

Effect of nitric oxide-donating agents on human monocyte cyclooxygenase-2.

Subretinal fluid from anterior ischemic optic neuropathy demonstrated by optical coherence tomography.

Genome-wide effects of the antimicrobial peptide apidaecin on translation termination in bacteria

Multimodal binding and inhibition of bacterial ribosomes by the antimicrobial peptides Api137 and Api88

An antimicrobial peptide that inhibits translation by trapping release factors on the ribosome

Structural and mechanistic insights into translation termination

RAPP-containing arrest peptides induce translational stalling by short circuiting the ribosomal peptidyltransferase activity

Transcription Inhibition by the Depsipeptide Antibiotic Salinamide A

Design of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho

Selective inhibition of human translation termination by a drug-like compound

Influence of Substitutions in the Binding Motif of Proline-Rich Antimicrobial Peptide ARV-1502 on 70S Ribosome Binding and Antimicrobial Activity

Activity, structure, and diversity of Type II proline-rich antimicrobial peptides from insects

Conserved Function of Drg GTPases in Promoting Protein Synthesis in Stalled Ribosomes

Drosophila immunity: the Drosocin gene encodes two host defence peptides with pathogen-specific roles

Distant Ribose 2'-O-Methylation of 23S rRNA Helix 69 Pre-Orders the Capreomycin Drug Binding Pocket at the Ribosome Subunit Interface

Doderlin: Isolation and Characterization of a Broad-Spectrum Antimicrobial Peptide from Lactobacillus acidophilus

Antibacterial Peptide Nucleic Acid-Antimicrobial Peptide (PNA-AMP) Conjugates: Antisense Targeting of Fatty Acid Biosynthesis.

Tetracenomycin X Inhibits Translation by Binding Within the Ribosomal Exit Tunnel

Rumicidins are a family of mammalian host-defense peptides plugging the 70S ribosome exit tunnel

A newly-identified mini-hairpin shaped nascent peptide blocks translation termination by a novel mechanism.

A rationally designed antimicrobial peptide from structural and functional insights of Clostridioides difficile translation initiation factor 1